Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 60.22B 8.96B 7.68B 7.19B 6.57B 12.4B 854B 12.52B 84.86B 33.03B 431B 33.64B 32.91B 1,427B | P/E 2026 * |
45.6x | P/E 2027 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise Value | 55.51B 8.26B 7.08B 6.63B 6.06B 11.43B 787B 11.55B 78.23B 30.45B 397B 31.01B 30.34B 1,316B | EV / Sales 2026 * |
6.87x | EV / Sales 2027 * | 5.77x |
| Free-Float |
61.13% | Yield 2026 * |
0.8% | Yield 2027 * | 1.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.12B | |
| -0.23% | +0.93% | +77.92% | +123.45% | 1,111B | |
| +0.58% | +0.86% | +53.26% | +64.48% | 658B | |
| +0.56% | +2.75% | +28.18% | +81.36% | 467B | |
| +0.92% | +3.57% | +43.82% | +44.21% | 369B | |
| +1.25% | +2.21% | +26.77% | +43.05% | 301B | |
| +3.02% | +5.68% | +5.09% | +17.04% | 256B | |
| -0.19% | +4.35% | +53.84% | +73.09% | 240B | |
| +2.86% | +3.86% | -16.20% | -51.83% | 207B | |
| +1.29% | +3.54% | +30.11% | +93.23% | 182B | |
| Average | +1.00% | +4.49% | +33.64% | +54.23% | 421.22B | |
| Weighted average by Cap. | +0.61% | +4.68% | +46.26% | +72.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.2B 1.03B 966M 882M 1.67B 115B 1.68B 11.39B 4.44B 57.86B 4.52B 4.42B 192B | 9.78B 1.46B 1.25B 1.17B 1.07B 2.02B 139B 2.03B 13.79B 5.37B 70.02B 5.47B 5.35B 232B |
| Net income | 1.36B 203M 174M 163M 149M 280M 19.31B 283M 1.92B 747M 9.74B 761M 744M 32.27B | 1.79B 267M 229M 214M 196M 369M 25.42B 373M 2.53B 983M 12.83B 1B 980M 42.48B |
| Net Debt | -4.71B -700M -600M -562M -514M -969M -66.76B -979M -6.63B -2.58B -33.68B -2.63B -2.57B -112B | -3.73B -555M -475M -445M -407M -768M -52.86B -775M -5.25B -2.04B -26.67B -2.08B -2.04B -88.33B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
